Cardiac biomarkers are of great importance in the timely, accurate diagnosis and management of acute coronary syndrome as well as the prognosis. Diagnosis in the golden period is of utmost importance to institute therapy at the earliest and possibly reverse the myocardial damage. Cardiac biomarkers are also a powerful tool for triaging. The global cardiac biomarkers market is expected to increase by USD 7 十亿, 以复合年增长率 (复合年增长率) 的 9.3% 从 2022 到 2028, according to the latest edition of the Global Cardiac Biomarkers Market Report.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global cardiac biomarkers market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the cardiac biomarkers industry.

该行业报告提供了全球市场的市场估计和预测, 其次是类型的详细分析, location of testing, 应用, 和地区. The global market for cardiac biomarkers can be segmented by type: albumin, creatine kinase-MB (CK-MB), low-density lipoproteins (LDL) and high-density lipoproteins (HDL), myoglobin, natriuretic peptides – B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP), troponins, 其他的. Cardiac biomarkers market is further segmented by location of testing: laboratory testing, point of care testing. 根据应用, the cardiac biomarkers market is segmented into: acute coronary syndrome, atherosclerosis, congestive heart failure, myocardial infarction, 其他的. 根据地区, the cardiac biomarkers market also can be divided into: 北美, 亚太地区, 欧洲, 世界其他地区 (排).

按类型:
– albumin
– creatine kinase-MB (CK-MB)
– low-density lipoproteins (LDL) and high-density lipoproteins (HDL)
– myoglobin
– natriuretic peptides – B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP)
– troponins
– 其他的

By location of testing:
– laboratory testing
– point of care testing

按申请:
– acute coronary syndrome
– atherosclerosis
– congestive heart failure
– myocardial infarction
– 其他的

按地区:
– 北美
– 亚太地区
– 欧洲
– 世界其他地区 (排)

The report also provides a detailed analysis of several leading cardiac biomarkers market vendors that include Abbott Laboratories, ACS Biomarker B.V., bioMerieux SA, Bio-Rad 实验室, 公司, 丹纳赫公司, F. 罗氏霍夫曼公司, 约翰逊 & 约翰逊, 诺华公司, QuidelOrtho Corporation, Randox Laboratories Ltd., 西门子公司, 赛默飞世尔科技公司, Tosoh Bioscience, 公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global cardiac biomarkers market.
– To classify and forecast the global cardiac biomarkers market based on type, location of testing, 应用, 地区.
– To identify drivers and challenges for the global cardiac biomarkers market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global cardiac biomarkers market.
– To identify and analyze the profile of leading players operating in the global cardiac biomarkers market.

为什么选择这份报告
– Gain a reliable outlook of the global cardiac biomarkers market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.